Research Reveals Opportunities to Better Address Blood Disorders Early in Life
Studies point to preventive measures and therapies that can set children on a healthier course with lifelong benefits SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Researchers report significant progress toward improving access to effective interventions to address blood disorders and promote healthy
Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023
Learn more about Servier’s leadership in mutant IDH inhibition at ASH booth #1347 BOSTON, Dec. 9, 2023 /PRNewswire/ — Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, will be presenting new data in acute myeloid leukemia (AML) at th
COP28: Canada Daily Highlights – December 9, 2023
DUBAI, United Arab Emirates, Dec. 9, 2023 /CNW/ – Daily event and announcement summary Today, Minister Guilbeault took the podium to deliver Canada’s National Statement, highlighting the country’s position, commitments and aspirations for addressing the global climate crisis,
InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets
HAUPPAUGE, N.Y., Dec. 9, 2023 /PRNewswire/ — Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level. Vigabatrin for Oral Solution, USP 500 mg has been found
New Hybrid Treatment Forces Cancer Cells to Starve
NEW YORK, Dec. 9, 2023 /PRNewswire/ — The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows. The work addressed multiple myeloma, a cancer that forms in blood cells that normally fight infections by making proteins that remove
“MET GALA” FOR LATINOS GATHERED THE MOST IMPORTANT 500+ LATINOS IN THE COUNTRY
The exclusive event honored John Leguizamo, Daytime Emmy award-winning Raúl de Molina and Fashion Designer Anne Fontaine NEW YORK, Dec. 9, 2023 /PRNewswire/ — The We Are All Human Foundation on Dec. 7 commemorated its third Annual We Are All Human Gala—an evening dedicated to mobilizing
WORKS Announces New Executive Director
Extensive Search and Recruitment Process Led by Envision Consulting LOS ANGELES, Dec. 9, 2023 /PRNewswire/ — Women Organizing Resources Knowledge and Services (WORKS), a leading nonprofit specializing in affordable housing development in Los Angeles County, is delighted to announce the appoint
COP28: Canada Daily Highlights – December 9, 2023
DUBAI, United Arab Emirates, Dec. 9, 2023 /CNW/ – Daily event and announcement summary Today, Minister Guilbeault took the podium to deliver Canada’s National Statement, highlighting the country’s position, commitments and aspirations for addressing the global climate crisis,
Blueprint Medicines’ Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
— HARBOR Part 1 trial data in indolent systemic mastocytosis showed elenestinib was well-tolerated with broad symptom improvement, supporting further development to expand and extend company’s SM franchise leadership — CAMBRIDGE, Mass., Dec. 9, 2023 /PRNewswire/ — Blueprint
Last Legend Off the Line: 2023 Chrysler 300C Ends Production
AUBURN HILLS, Mich., Dec. 9, 2023 /PRNewswire/ — Final 2023 Chrysler 300C model rolls off production line at Brampton (Ontario) Assembly PlantBrampton team members commemorate the final production of the HEMI®-powered vehicle — a Velvet Red 2023 Chrysler 300CFinal production of the 2023 Chr
